Is LSA (Morning Glory) legal in Switzerland?

Legal status

Controlled. The federal schedule ordinance BetmVV-EDI carries LSA in list e, where the entry reads „Lysergsäureamid / Ergin“. The entry names the lysergamide by its chemical name and its common name together. Article 1 of the ordinance defines the controlled set as narcotics, psychotropic substances, raw materials and products with a presumed narcotic like effect, precursors and auxiliary chemicals, and article 1(2) then extends each named entry to its salts, esters, ethers, carbamates and stereoisomers and to preparations containing it. The model is closed but extended, so a chemical resemblance to the list e entry is not by itself enough to bring a compound inside it. Article 2 assigns lists a to d to Annexes 1 to 5 and list e to Annex 6. The German consolidation read for this row is dated 13 March 2026, and the German, French and Italian texts are equally authoritative.

Consequences if caught

Capital exposure: none. Switzerland has no death penalty and the Betäubungsmittelgesetz authorises no life term either, so the ceiling is 20 years: BetmG article 19(2) defines the aggravated forms of the offence and StGB article 40 supplies that maximum precisely because the drug act does not reach beyond it. What brings street conduct inside article 19 at all is the list e placement of the entry „Lysergsäureamid / Ergin“ rather than the weight carried; quantity then separates the ordinary case from the aggravated serious case. Switzerland fits none of the three threshold models cleanly, because it combines one federal statutory cannabis figure, substance specific Federal Supreme Court thresholds for the aggravated serious case, and conduct based offences for which quantity is not the sole determinant, so no settled weight can be quoted here. Unauthorised consumption is a separate offence under BetmG article 19a and is not silently treated as trafficking.

If prescribed or medical

LSA sits in list e of BetmVV-EDI, entered as „Lysergsäureamid / Ergin“, and the only country level rule this dossier establishes for a person carrying a drug in Switzerland is the personal use regime: BetmG article 19a keeps unauthorised intentional consumption punishable in its own right, article 19b makes the preparation of a negligible quantity for one's own consumption nonpunishable, together with qualifying free sharing for simultaneous joint consumption, and article 19b(2) fixes that negligible quantity at 10 g of cannabis and at nothing else. The figure is federal law rather than a cantonal tolerance, so it gives no margin to a list e substance such as LSA, and cantonal police and prosecutors administer the rule without being able to replace it. No prescription, import certificate or traveller exemption specific to LSA was established in this dossier, so nothing here authorises a foreign prescription at the Swiss border.

Documentation

Carry no LSA into Switzerland on the strength of this row, and keep any medicine you are lawfully entitled to in its original dispensing packaging with the prescription and a prescriber's letter naming the patient, the active ingredient and the dose. The provenance is the EDI ordinance BetmVV-EDI in its German consolidation dated 13 March 2026, read at the Fedlex classified compilation on 18 September 2026, where the list e entry reads „Lysergsäureamid / Ergin“; the penalty articles are BetmG article 19 with StGB article 40 supplying the 20 year maximum, and the 94 page consolidation was read through its final page, so no further drug schedule follows it.

Drug laws and enforcement change and vary within a country. This is not legal advice. Always confirm with Switzerland’s embassy or official drug authority before traveling; penalties can be severe, including imprisonment.